Expression of Apolipoprotein A1 in Colonic Adenocarcinoma

Anticancer Research

Volumn 23, Issue 5 B, 2003, Pages 4161-4167

  Tachibana, Masayoshi ^a,b,c   Ohkura, Yasuo ^a   Kobayashi, Yasuhito ^a   Sakamoto, Hirohiko ^a   Tanaka, Yoichi ^a   Watanabe, Junko ^a   Amikura, Katsumi ^a   Nishimura, Yoji ^a   Akagi, Kiwamu ^a  

^a SAITAMA CANCER CENTER   (Japan)

^b REDS Group   (Japan)

^c NIIGATA UNIVERSITY   (Japan)

Author keywords

Apoliporotein A1; Cancer progression; Colonic adenocarcinoma

Indexed keywords

AMINO ACID; APOLIPOPROTEIN A1; PROTEOME;

ADULT; AGED; ARTICLE; COLON ADENOCARCINOMA; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; MASS SPECTROMETRY; METASTASIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMALL INTESTINE; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; APOLIPOPROTEIN A-I; COLONIC NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PROTEOMICS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC;

EID: 0344009650     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Fearon ER and Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61: 759-767, 1990.
2. Schoeppner HL, Raz A, Ho SB and Bresalier RS: Expression of an endogenous galactose-binding lectin correlates with neoplastic progression in the colon. Cancer 75: 2818-2826, 1995.
3. Ishikawa T, Ichikawa Y, Mitsuhashi M, Momiyama N, Chishima T. Tanaka K, Yamaoka H, Miyazaki K, Nagashima Y, Akitaya T and Shimada H: Matrylisin is associated with progression of colorectal tumor. Cancer Lett 107: 5-10, 1996.
4. INK4A and is a region of low proliferation. Am J Pathol 159: 1613-1617, 2001.
5. Jungblut PR, Zimny-Arndt U, Zeindl-Eberhart E, Stulik J, Koupilova K, Pleissner KP, Otto A, Muller EC, Sokolowska-Kohler W, Grabher G and Stoffler G: Proteomic in human disease: Cancer, heart and infectious diseases. Electrophoresis 20: 2100-2110, 1999.
6. Chambers G, Lawrie L, Cash P and Murray GI: Proteomics: a new approach to sudy of disease: J Pathol 192: 280-288, 2000.
7. Emmert-Buck MR, Gillespie JW, Paweletz CP, Ornstein DK, Basrur V, Appella E, Wang QH, Huang J, Hu N, Taylor P and Petricoin EF 3rd: An approach to proteomic analysis of human tumors. Mol Carcinog 27: 158-165, 2000.
8. Simpson RJ and Dorow DS: Cancer proteomics: from signaling networks to tumor markers. Trends Biotechnol 19: S40-S48, 2001.
9. Wu W and Kavanagh JJ: Proteomics in cancer research. Int J Gynecol Cancer 12: 409-423, 2002.
10. Petricoin EF, Zoon KC, Kohn EC, Barrett JC and Liotta LA: Clinical proteomics: translating benchside promise into bedside reality. Nature Rev Drug Discov 1: 683-695, 2002.
11. Pucci-Minafra I, Fontana S, Cancemi P, Basirico L, Caricato S, Minafra S: A contribution to breast cancer cell proteomics: Detection of new sequences. Proteomics 2: 919-927, 2002.
12. Pucci-Minafra I, Fontana S, Cancemi P, Alaimo G and Minafra S: Proteomic patterns of cultured breast cancer cells and epithelial mammary cells. Ann NY Acad Sci 963: 11122-11139, 2002.
13. Ahram M, Best CJ, Flaig MJ, Gillespie JW, Leiva IM, Chuaqui RF, Zhou G, Shu H, Duray PH, Linehan WM, Raffeld M, Ornstein DK, Zhao Y, Petricoin EF 3rd and Emmert-Buck MR: Proteomic analysis of human prostate cancer. Mol Carcinogenesis 33: 9-15, 2002.
14. Vlahou A, Schellhammer PF, Mendrinos S, Patel K, Kondylis FI, Gong L, Nasim S and Wright GL Jr: Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. Am J Pathol 158: 1491-1502, 2001.
15. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC and Liotta LA: Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359: 572-577, 2002.
16. Petricoin EF 3rd, Ornstein DK, Paweletz CP, Ardekani A, Hackett PS, Hitt BA, Velassco A, Trucco C, Wiegand L, Wood K, Simone CB, Levine PJ, Linehan WM, Emmert-Buck MR, Steinberg SM, Kohn EC and Liotta LA: Serum proteomic patterns for detection of prostate cancer. J Ntl Cancer Inst 94: 1576-1578, 2002.
17. Shevchenko A, Wilm M, Vorm O and Mann M: Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68: 850-858, 1996.
18. Petropoulos I and Zakin MM: Transferrin gene as a model for liver-specific gene expression. Biol Cell 77: 63-65, 1993.
19. Glickman RM and Green PH: The intestine as a source of apolipoprotein A1. Proc Natl Acad Sci USA 74: 2569-2573, 1977.
20. Glickman RM, Green PH, Green PH, Lees RS and Tall A: Apoprotein A-I synthesis in normal intestinal mucosa and in Tangier disease. N Engl J Med 299: 1424-1427, 1978.
21. Wu A-L and Windmueller HG: Identification of circulating apolipoproteins synthesized by rat small intestine in vivo. J Biol Chem 253: 2525-2528, 1978.
22. Wu A-L and Windmueller HG: Relative contributions by liver and intestine to individual plasma apolipoproteins in the rat. J Biol Chem 254: 7316-7322, 1979.
23. Green PH, Lefkowitch JH, Glickman RM, Riley JW, Quinet E and Blum CB: Apolipoprotein localization and quantitation in human intestine. Gastroenterol 83: 1223-1230, 1982.
24. Basque JR, Lévy E, Beaulie JF and Menard D: Apolipoproteins in human fetal colon: Immunolocalization, biogenesis, and hormonal regulation. J Cell Biochem 70: 354-365, 1998.
25. Shemer R, Kafri T, O'Connell A, Eisenberg S, Breslow JL and Razin A: Methylation changes in the apolipoprotein AI gene during embryonic development of the mouse. Proc Natl Acad Sci USA 88: 11300-11304, 1991.
26. Shemer R, Walsh A, Eisenberg S, Breslow JL and Razin A: Tissue-specific methylation patterns and expression of the human apolipoprotein AI gene. J Biol Chem 265: 1010-1015, 1990.
27. Reisher SR, Hughes TE, Ordovas JM, Schaefer EJ and Feinstein SI: Increased expression of apolipoprotein genes accompanies differentiation in the intestinal cell line Caco-2. Proc Natl Acad Sci USA 90: 5757-5761, 1993.
28. Ricchi P, Pignata S, Di Popolo A, Memoli A, Apicella A, Zarrilli R and Acquaviva AM: Effect of aspirin on cell proliferation and differentiation of colon adenocarcinoma Caco-2 cells. Int J Cancer 73: 880-884, 1997.
29. De Smet C, De Backer O, Faraoni I, Lurquin C, Brasseur F and Boon T: The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc Natl Acad Sci USA 93: 7149-7153, 1996.
30. Fang JY, Zhu SS, Xiao SD, Jiang SJ, Shi Y, Chen XY, Zhou XM and Qian LF: Studies on the hypomethylation of c-myc, c-Ha-ras oncogenes and histopathological changes in human gastric carcinoma. J Gatroenterol Hepatol 11: 1079-1082, 1996.
31. Hattori M, Sakamoto H, Satoh K and Yamamoto T: DNA demethylase is expressed in ovarian cancers and the expression correlates with demethylation of CpG sites in the promoter region of c-erbB-2 and survivin genes. Cancer Lett 169: 155-164, 2001.
32. Watt PM, Kumar R and Kees UR: Promoter demethylation accompanies reactivation of the HOXII proto-oncogene in leukemia. Genes Chromosomes Cancer 29: 371-377, 2000.
33. Trougakos IP and Gonos ES: Clusterin/aplipoprotein J in human aging and cancer. Int J Biochem Cell Biol 34: 1430-1448, 2002.
34. Steinberg J, Oyasu R, Lang S, Sintich S, Rademaker A, Lee C, Kozlowski JM and Sensibar JA: Intracellular levels of SPG-2 (clusterin) correlate with tumor grade in prostate cancer. Clin Cancer Res 3: 1707-1711, 1997.
35. Kadomatsu K, Anzano MA, Slayter MV, Winokur TS, Smith JM and Sporn MB: Expression of sulfated glycoprotein 2 is associated with carcinogenesis induced by N-nitroso-N-methylurea in rat prostate and seminal vesicle. Cancer Res 53: 1480-1483, 1993.
36. Rassart E, Bedirian A, Do Carmo S, Guinard O, Sirois J, Terrisse L and Milne R: Apolipoprotein D. Biochim Biophys Acta 1482: 185-198, 2000.
37. Diez-Itza I, Vizoso F, Merino AM, Sanchez LM, Tolivia J, Fernandez J, Ruibal A and Lopez-Otin C: Expression and prognostic significance of apoliporotein D in breast cancer. Am J Pathol 144: 310-320, 1994.
38. Aspinall JO, Bentel JM, Horsfall DJ, Haagensen DE, Marshall VR and Tilley WD: Differential expression of apolipoprotein-D and prostate specific antigen in benign and malignant prostate tissues. J Urol 154: 622-628, 1995.